SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Rinne J.O.)
 

Search: WFRF:(Rinne J.O.) > (2010-2014) > Positron emission t...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Leinonen, V (author)

Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • 2013-02-11
  • Wiley,2013
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-261037
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-261037URI
  • https://doi.org/10.1111/ene.12102DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BACKGROUND AND PURPOSE: This study determined the correlation between uptake of the amyloid positron emission tomography (PET) imaging agent [(18) F]flutemetamol and amyloid-β measured by immunohistochemical and histochemical staining in a frontal cortical biopsy.METHODS: Fifteen patients with possible normal pressure hydrocephalus (NPH) and previous brain biopsy obtained during intracranial pressure monitoring underwent [18F]flutemetamol PET. Seven of these patients also underwent [11C] Pittsburgh compound B (PiB) PET. [18F]Flutemetamol and [11C]PiB uptake was quantified using standardized uptake value ratio (SUVR) with the cerebellar cortex as a reference region. Tissue amyloid-β was evaluated using the monoclonal antibody 4G8, Thioflavin-S and Bielschowsky silver stain.RESULTS: [18F]Flutemetamol and [11C]PiB SUVRs correlated with biopsy specimen amyloid-β levels contralateral (r = 0.86, P < 0.0001; r = 0.96, P = 0.0008) and ipsilateral (r = 0.82, P = 0.0002; r = 0.87, P = 0.01) to the biopsy site. Association between cortical composite [(18) F]flutemetamol SUVRs and [11C]PiB SUVRs was highly significant (r = 0.97, P = 0.0003).CONCLUSIONS: [18F]Flutemetamol detects brain amyloid-β in vivo with moderate to high sensitivity and high specificity. This agent, therefore, represents a valuable new tool to study and verify the presence of amyloid-β pathology, both in patients with possible NPH and among the wider population.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Rinne, J O (author)
  • Virtanen, K A (author)
  • Eskola, O (author)
  • Rummukainen, J (author)
  • Huttunen, J (author)
  • von Und Zu Fraunberg, M (author)
  • Nerg, O (author)
  • Koivisto, A M (author)
  • Rinne, J (author)
  • Jääskeläinen, J E (author)
  • Buckley, C (author)
  • Smith, A (author)
  • Jones, P A (author)
  • Sherwin, P (author)
  • Farrar, G (author)
  • McLain, R (author)
  • Kailajärvi, M (author)
  • Heurling, Kerstin,1982-Uppsala universitet,Radiologi,Nuklearmedicin och PET(Swepub:uu)kerhe556 (author)
  • Grachev, I D (author)
  • Uppsala universitetRadiologi (creator_code:org_t)

Related titles

  • In:European Journal of Neurology: Wiley20:7, s. 1043-521351-51011468-1331

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view